Critical Care · 2004 · 261 citations · 38 references
MedicineHematologyPharmacoeconomicsCost-effectiveness AnalysisTransfusion MedicineAnemiaBlood Transfusion ManagementRed Blood Cell TransfusionTransfusion SupportTransfusion TherapyCost-effectivenessCost-effectiveness Analysis PerspectiveErythropoiesis-stimulating Agent UseErythropoiesis-stimulating TherapyRed Blood Cell Transfusion Load
Recombinant human erythropoietin (rhEPO) has been shown to decrease the packed red blood cell (PRBC) transfusion requirement by about 20% among ICU patients admitted for longer than 48 hours. Despite this, its use has not been widely instituted, in part due to its cost.
38
Intensive Insulin Therapy in Critically Ill Patients
Greet Van den Berghe, Pieter Wouters, Frank Weekers et al. · New England Journal of Medicine · 2001 · 10K citations · Full text